Narrative review / 2018
Recent large-scale studies have failed to demonstrate benefits of fish oil supplements on cardiovascular outcomes and mortality.
Fish and fish oil preparations supply long-chain omega-3 fatty acids like EPA and DHA. While early observational studies and some clinical trials documented cardiovascular benefits such as reduced atherosclerosis, myocardial infarction, and arrhythmias, recent large-scale studies failed to demonstrate cardiovascular or mortality benefits. This narrative review evaluates trials assessing the role of fish oil in cardiovascular diseases.
- Study type
- Narrative review
- Who was studied
- Adults evaluating fish oil and cardiovascular outcomes
- What was measured
- Cardiovascular outcomes, mortality, and cardioprotection
THE PAPER
Fish, Fish Oils and Cardioprotection: Promise or Fish Tale?
Goel A, Pothineni NV, Singhal M, Paydak H, Saldeen T, Mehta JL. Int J Mol Sci, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.